期刊文献+

老年前列腺癌去势患者性激素水平变化及血栓危险因素分析 被引量:2

Changes of sex hormone and risk factors associated with thrombosis in older men with castrated prostatic cancer
下载PDF
导出
摘要 目的研究老年前列腺癌患者去势后性激素水平变化,进一步探讨性激素对血栓危险因素的影响。方法选择247例>65岁老年患者,其中122例去势前列腺癌患者(去势组)、61例行根治性前列腺癌切除术的未去势前列腺癌患者(未去势组)和64例非前列腺癌(非前列腺癌组)患者。分别测定睾酮、雌激素、黄体生成素(LH)、卵泡刺激素(FSH)、泌乳素、孕激素,同时测定了血小板计数(PLT)、花生四烯酸(AA)诱导的血小板聚集率、二磷酸腺苷(ADP)诱导的血小板聚集率、凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)、D-二聚体(DD)、抗凝血酶-Ⅲ(AT-Ⅲ)、纤维蛋白原(FIB)、国际标准化比值(INR)。结果老年前列腺癌患者接受去势手术治疗后睾酮、雌激素、孕激素水平明显降低,LH、FSH显著升高,但泌乳素无明显变化,雌、雄激素比显著升高;同时AA诱导的血小板聚集率、ADP诱导的血小板聚集率、DD及FIB显著升高,INR显著降低,PT和APTT显著缩短;但PLT和AT-Ⅲ无明显变化。结论老年前列腺癌患者去势治疗后性激素水平紊乱,主要表现为睾酮、雌激素水平明显降低,但雌激素降低幅度小于雄激素;血小板和凝血活性显著增强,提示性激素水平紊乱可能参与凝血系统激活,增加血栓事件危险。 Objective To study the changes of sex hormone levels in old patients with castrated prostatic cancer, and to detect the relationship between changes of sex hormone levels and risk factors for thrombosis. Methods Two hundred forty seven elderly patients aged over 65,including 122 castrated patients,61 radical prostatectomy patients, and 64 non-prostatic cancer patients. Testosterone, estradiol, luteal hormone, follicle stimulating hormone (FSH), prolactin, progesterone, blood platelets eount(PLT), aggrega- tion of platelets induced by araehidonic acid (AA),aggregation of platelets induced by adenosine diphosphate (ADP),blood prothrombin time(PT), activated partial thromboplastin time(APTT), D-dimers(DD), antithro-m- Ⅲ (AT- Ⅲ ), fibrinogen(FIB), international normal- ized ratio(INR) were measured and compared between groups. Results In patients with castrated prostatic cancer,Testosterone,estra- diol, and progesterone levels decreased significantly, LH and FSH increased significantly ,change of prolaetin was not significantly, E2/ T were elevated significantly;Aggregation of platelets induced either by AA or ADP increased significantly;PT and AVFT shortened significantly,INR decreased significantly,DD and FIB elevated significantly. Differences in AT-m and PLT were not significantly. Conclusions Levels of sex hormone in patients experienced castrated prostatic cancer changed greatly,platelets and coagulating fac- tors were activated accordingly. It suggested that there might be relationship between decreased sex hormone levels and risk factors for thrombotic events in old male patients.
作者 徐昆 司全金
出处 《中华保健医学杂志》 2013年第4期323-325,共3页 Chinese Journal of Health Care and Medicine
关键词 前列腺癌 睾丸切除术 睾酮 血栓形成 危险因素 Prostatic neoplasms Orchiectomy Testosterone Thrombosis Risk factors
  • 相关文献

参考文献4

二级参考文献37

  • 1徐辉,蔡凯,夏明凯,李介华,黄超龙,张小勇,王丽娜,冯建洪.冠心病患者血D-二聚体和血栓前体蛋白含量变化及其临床意义——附148例检测结果[J].新医学,2005,36(3):147-148. 被引量:5
  • 2郝金红,樊瑛,杨树森.纤维蛋白原、D-二聚体、脂蛋白(a)、外周血白细胞与冠心病的相关研究[J].齐齐哈尔医学院学报,2006,27(12):1409-1411. 被引量:13
  • 3Yarnell JWG,Baker IA,Sweetnam PM,et al.Fibrinogen,viscosity,and white blood cell count are major risk factors for ischemic heart disease.The caerphilly and speedwell collaborative heart diseases studies[J].Circulation,1991,83:836.
  • 4Paramonov AD,Moiseev SV,Fomin VV,et al.Ferritin and other acute phase proteints in various forms of coronary heart disease[J].Klin Med Mosk,2005,83(2):252-291.
  • 5Goracy I,Goracy J,Brykczynski M,et al.Fibrinogen(Fb) concentrations in patients with ischemic heart disease undergoing coronary angiography[J].Pol Arca Med Wewn,2001,106(1):551-556.
  • 6Hamsten,A,Eriksson P.Fibrinolysis and atherosclerosis[J].Baillieres Clin Haematol,1995,8(2):345-363.
  • 7Ganti AK,Potti A,Yegnanarayan R.Plasma tissue plasminogen ctivator and plasminogen activator inhibitor-1 levels in acute myocardial infarction[J].Pathophysiol Haemost Thromb.2002,32(2):80-84.
  • 8Saed GM,Diamond MP.Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritomeal and adhesion fibroblasts[J].Fertil Sterol,2003,79(1):164-168.
  • 9Sullivan ML,Martinex CM,Gennis P,et al.The cardiac toxicity of anabolic steroids[J].Prog Cardiovasc Dis,1998,41(1):1-15.
  • 10Zhu Y,Farrehi PM,Fay WP.Plasminogen activator inhibitor type-1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice[J].Circulation,2001,103(25):3105-3110.

共引文献64

同被引文献26

  • 1中华神经科学会 中华神经外科学会.各类脑血管病诊断要点.中华神经科杂志,1996,:379-380.
  • 2Hamberg M, Svensson J, Samuelsson B. Thromboxanes:a new group of biologically active compounds derived from prostaglandin endopero'xides[J]. Proc Natl Aead Sci USA, 1975, 72: 2994-2998.
  • 3Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets.I.Acetylation of particulate fraction protein[J]. J Clin Invest, 1975, 56: 624-632.
  • 4Antithrombotic Trialists'Collaboration. Collaboration meta-analysis of randomized trials of antiplatelet therapy for prevention of death,myocardial infartion,and stroke in high risk patients[J]. BMJ, 2002, 324: 71-86.
  • 5Patrono C, Rocca B. Aspirin: promise and resistance in the new millen- nium[J]. Arterioscler Thromb Vasc Biol, 2008, 28: s25-s32.
  • 6Patrono C. Aspirin resistance: definition, mechanisms and clinical read- outs[J]. J Thromb Haemost, 2003, 1: 1710-1713.
  • 7Pusch G, Feher G, Koltai K, et al. Aspirin resistance:focus on clinical endpoints[J]. J Cardiovasc Pharmacol, 2008, 52: 475-484.
  • 8Thpmas C, Corinne F, Jacques Q, et al. Aspirin noncompliance is the majorcau-se of"asprirn resistance" in patients undergoing coronary stenting [J]. Am Heart J, 2009, 157: 889-893.
  • 9Floyd CN, Ferro A. Mechanisms of aspirin resistance [J]. Pharmacol.Ther, 2014, 141: 69-78.
  • 10中华医学会神经病学分会脑血管病学组急性缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2011,39:154-160.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部